Dispatches from the Land of Alzheimer's

Daniel Gibbs is a retired general neurologist with mild Alzheimer's dementia. He has written previously about his experiences as seen from two points of view, doctor and patient, in A Tattoo on my Brain: A Neurologist's Personal Battle against Alzheimer's Disease, Cambridge University Press, 2021 and 2023 (revised edition).

1. Physician heal thyself; 2. Evaluating new advances in Alzheimer's research – separating hype from fact; 3. Alzheimer's dementia or Alzheimer's disease – what's the difference and why should we care?; 4. The first patient with Alzheimer's disease; 5. Kidnapped in Kinshasa; 6. Smell, disgust and Alzheimer's; 7. Apolipoprotein-4 (APOE-4): bad for the brain and bad for the heart; 8. Lost in the fog of Alzheimer's; 9. My father's 'stuff'; 10. Face blindness during a pandemic; 11. Biomarkers for Alzheimer's disease; 12. Olfactory impairment in Covid-19 and Alzheimer's; 13. Alzheimer's disease and work; 14. Crossword controversies; 15. Can loneliness increase risk for dementia?; 16. Excessive laxative use and dementia; 17. Dog dementia (canine cognitive dysfunction); 18. The possible role of brain inflammation in Alzheimer's disease may be more significant in APOE-4 carriers; 19. Surprisingly good news about the acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine); 20. More about the importance of exercise; 21. Rolling on the river; 22. The MIND Diet revisited; 23. My photographs, then and now; 24. Does cataract surgery really decrease the risk of dementia?; 25. Hearing loss, aphasia and dementia; 26. To sleep, perchance to dream; 27. The amyloid hypothesis is not dead, but it may be gasping for breath; 28. Could Lecanemab offer a ray of hope?; 29. A fatal case of multiple brain hemorrhages associated with Lecanemab; 30. Cerebral amyloid angiopathy (CAA) – should it be a contraindication for drugs like Lecanemab?; 31. Hitting the sweet spot in the spectrum of Alzheimer's disease for future trials of anti-amyloid medications; 32. Disappointing results of two human trials of monoclonal antibodies in Parkinson's disease; 33. Repurposing old drugs for Alzheimer's treatment; 34. Writing while impaired; 35. Spreading the word; 36. Saying goodbye to Lizzy G; 37. Amyloid and tau PET scans of my brain; 38. Running on a field of dreams; 39. Living in the moment.